Padilla, Francisco
Cardiología Clínica e Intervencionista Tarascos, Guadalajara, Mexico (F.P.).
2 papers on CoChatORCID 0000-0002-5900-2284
Most cited papers
- Verified · note
Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial
Zelniker, T. A., Bonaca, M. P., Furtado, R. H. M., Mosenzon, O., Kuder, J. F., Murphy, S. A., Bhatt, D. L., Leiter, L. A., McGuire, D. K., Wilding, J. P. H., et al. (2020) · Circulation
Diabetes Treatment and ManagementAtrial Fibrillation Management and Outcomes
Cited by 459
- Verified
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
Bhatt, D. L., Steg, P. G., Mehta, S. R., Leiter, L. A., Simon, T., Fox, K., Held, C., Andersson, M., Himmelmann, A., Ridderstråle, W., et al. (2019) · The Lancet
Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics
Cited by 209
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free